authors
- Pond, Gregory
- Siu, LL
- Moore, MJ
- Oza, AM
- Hirte, H
- Winquist, E
- Goss, G
- Hudes, G
- Degendorfer, P
- Townsley, CA
Nomograms to predict serious adverse events (SAEs) in patients (pts) enrolled in phase II clinical trials of molecularly targeted agents (MTAs)
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- June 20, 2007
has subject area
- 1103 Clinical Sciences (FoR)
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- Journal of Clinical Oncology Journal